Celsius Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Celsius Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.32B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $653.60M | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $314.27M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $130.73M | Apr 19, 2023 |
| FY2019 | Dec 31, 2019 | $75.15M | May 13, 2021 |
| FY2019 | Dec 31, 2018 | $52.60M | May 13, 2021 |
| FY2018 | Dec 31, 2017 | $36.16M | Mar 14, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.52B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.36B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $1.32B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $653.60M | Mar 3, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.00M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $145.07M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $226.80M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($187.28M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $3.94M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $8.52M | Apr 19, 2023 |
| FY2019 | Dec 31, 2019 | $9.97M | May 13, 2021 |
| FY2019 | Dec 31, 2018 | ($11.21M) | May 13, 2021 |
| FY2018 | Dec 31, 2017 | ($8.24M) | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | ($3.07M) | Mar 8, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.06M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $155.73M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $266.37M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($157.80M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($4.09M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $7.91M | Apr 19, 2023 |
| FY2019 | Dec 31, 2019 | ($1.45M) | May 13, 2021 |
| FY2019 | Dec 31, 2018 | ($10.64M) | May 13, 2021 |
| FY2018 | Dec 31, 2017 | ($8.08M) | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | ($2.84M) | Mar 8, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.12B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.54B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $314.02M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $131.29M | Mar 16, 2022 |
| FY2019 | Dec 31, 2019 | $90.38M | May 13, 2021 |
| FY2019 | Dec 31, 2018 | $34.63M | May 13, 2021 |
| FY2018 | Dec 31, 2017 | $27.11M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $17.72M | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.18B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $542.46M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $447.87M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $357.49M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $96.97M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $26.96M | Mar 16, 2022 |
| FY2019 | Dec 31, 2019 | $26.92M | May 13, 2021 |
| FY2019 | Dec 31, 2018 | $22.82M | May 13, 2021 |
| FY2018 | Dec 31, 2017 | $9.96M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $6.82M | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $399.93M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $264.04M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $40.09M | Mar 2, 2026 |
| FY2024 | Dec 31, 2021 | $217.05M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $104.33M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $63.46M | Apr 19, 2023 |
| FY2019 | Dec 31, 2018 | $11.80M | May 13, 2021 |
| FY2019 | Dec 31, 2017 | $17.15M | May 13, 2021 |
| FY2018 | Dec 31, 2016 | $10.89M | Mar 14, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Apr 19, 2023 |
| FY2019 | Dec 31, 2019 | 0 | May 13, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 13, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Apr 19, 2023 |
| FY2019 | Dec 31, 2019 | 0 | May 13, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 13, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $398.87M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $890.19M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $755.98M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $614.16M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $16.26M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $43.25M | Mar 16, 2022 |
| FY2021 | Dec 31, 2019 | $23.09M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $7.74M | Mar 11, 2021 |
| FY2018 | Dec 31, 2017 | $14.19M | Mar 14, 2019 |
| FY2018 | Dec 31, 2016 | $11.75M | Mar 14, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $676.93M | Mar 2, 2026 |